Seaweeds and Their Natural Products for Preventing Cardiovascular Associated Dysfunction
Cardiovascular disease (CVD), which involves the onset and exacerbation of various conditions including dyslipidemia, activation of the renin–angiotensin system, vascular endothelial cell damage, and oxidative stress, is a leading cause of high mortality rates and accounts for one-third of deaths wo...
Main Authors: | Bomi Ryu, Young-Sang Kim, You-Jin Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/9/507 |
Similar Items
-
Prevention of cardiovascular disease through modulation of endothelial cell function by dietary seaweed intake
by: Kazuo Yamagata
Published: (2021-05-01) -
Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
by: Manuel Gómez-Guzmán, et al.
Published: (2018-07-01) -
Increment of the effectiveness of treating hypertension and dyslipidemia using a triple fixed-dose combination and the vascular age concept
by: O. V. Tsygankova, et al.
Published: (2020-09-01) -
Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia
by: Siping Dai, et al.
Published: (2018-01-01) -
Associations of Dietary Intake with Cardiovascular Disease, Blood Pressure, and Lipid Profile in the Korean Population: a Systematic Review and Meta-Analysis
by: Jeongseon Kim, et al.
Published: (2020-01-01)